|
| |
F10
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 18245654 |
Factor XDebrecen: Gly204Arg mutation in factor X causes the synthesis of a non-secretable protein and severe factor X deficiency |
| 18062812 |
Several strong FXa-binding snake venom group IIA secreted phospholipases A2 that disrupt the function of the coagulation cascade by interacting with FXa by the non-catalytic PL-independent mechanism, were identified. |
| 16580898 |
Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator) |
| 18267072 |
Study shows that FX binds to the Adenovirus 5 hexon, not fiber, via an interaction between the FX Gla domain and hypervariable regions of the hexon surface. |
| 17973648 |
Possible locations of prothrombin binding to prothrombinase are indicated by simulation of the docked complex |
| 18000611 |
maximal thrombin generation in plasma requires membranes with a density of 10-20 mol% PS; thrombin formed in situ induces externalization of PS to approx 10 mol% in a substantial platelet subpopulation. |
| 17726015 |
Role of the alpha-helix 163-170 in FXA catalytic activity is reported. |
| 17635109 |
The epidermal growth factor domain 1 of activated factor X (fXa) plays a spacer function in holding the active site of fXa above the membrane surface. |
| 17646160 |
peptide VP311-325 represents both an Activated protein C and fXa binding region in fVa. |
| 17588602 |
The crystal structure of NAP5 bound at the active site of gamma-carboxyglutamic acid domainless factor Xa (des-fXa) has been determined at 3.1 A resolution. | →View more information from publications. |
Recent Publications on F10: |  |
Vetiver grass, Vetiveria zizanioides: a choice plant for phytoremediation of heavy metals and organic wastes.
Glasshouse and field studies showed that Vetiver grass can produce high... | 29th October, 2009
| Chemical Sciences Building (F10), School of Chemical Sciences and
| Int J Phytoremediation. 2009 Oct-Dec;11(8):664-91.
|
Nanowire Biocompatibility in the Brain - Looking for a Needle in a 3D Stack.
We investigated the brain-tissue response to nanowire implantations in the... | 23rd October, 2009
| Neuronano Research Center, BMC F10, Lund University, SE-221 84 Lund,
| Nano Lett. 2009 Oct 21.
DOI Direct Link |
The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation.
As a new anticancer treatment option, vaccinia virus (VACV) has shown... | 21st October, 2009
| Genelux Corporation, San Diego Science Center, 3030 Bunker Hill St., Ste.
| Mol Genet Genomics. 2009 Oct;282(4):417-35. Epub 2009 Aug 22.
DOI Direct Link |
Long-term outcome of in-patients with substance use disorders: A study from North India.
BACKGROUND: Research into substance use disorders (SUD) has been unable to... | 14th October, 2009
| Department of Psychiatry, Postgraduate Institute of Medical Education and
| Indian J Psychiatry. 2008 Oct;50(4):269-73.
DOI Direct Link |
Development of physiological resistance and its stage specificity in Culex quinquefasciatus after selection with deltamethrin in Assam, India.
The study investigated the development and stage specificity of... | 13th October, 2009
| Medical Entomology Division, Defence Research Laboratory, Tezpur, Assam,
| Mem Inst Oswaldo Cruz. 2009 Aug;104(5):673-7.
|
→View more research publications. |
Press Releases on F10:
|
 |
| Reportlinker Adds Prefeasibility Report - Specaility and Multi- Speciality Hospitals (2009) |
26th October, 2009 |
Reportlinker |
NEW YORK, Oct. 26 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Oncolytics Biotech(R) Inc. Collaborators Present Reovirus Research at Replicating Oncolytic Virus Meeting |
23rd March, 2009 |
Oncolytics Biotech Inc. |
CALGARY, March 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced results of two preclinical studies that were presented at the Fifth International Meeting on
|
| Oncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting |
22nd October, 2008 |
Oncolytics Biotech Inc. |
CALGARY, Oct. 22 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Prof. Hardev Pandha of The Royal Surrey Hospital, U
|
| Effect of CytoregR on Biomarkers in B16-F10 Murine Melanoma |
1st January, 1970 |
Cytorex Biosciences |
Effect of CytoregR on
Biomarkers in B16-F10 Murine Melanoma
|
F10 results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for F10,
or search for F10 on BioPortfolio's antibody search engine.
This page has been viewed 423 times
Recent Search Terms used to find this page: F10 coagulation factor X | factor X coagulation | what is the name of factor ten clotting factor | F10 AND coagulation factor X | hexon factor x coagulation adenovirus | factor x coagulation | F10 coagulation protein | F10 coagulation factor X | fiber F) F10 factors | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
